Table: begin end state 1 11 cytoplasmic 12 31 transmembrane 32 42 non-cytoplasmic 43 62 transmembrane 63 94 cytoplasmic 95 120 transmembrane 121 127 non-cytoplasmic 128 149 transmembrane 150 157 cytoplasmic 158 180 transmembrane 181 208 non-cytoplasmic 209 228 transmembrane 229 239 cytoplasmic 240 262 transmembrane 263 283 non-cytoplasmic 284 309 transmembrane 310 337 cytoplasmic 338 357 transmembrane 358 362 non-cytoplasmic 363 387 transmembrane 388 399 cytoplasmic 400 417 transmembrane 418 422 non-cytoplasmic 423 441 transmembrane 442 452 cytoplasmic 453 473 transmembrane 474 480 non-cytoplasmic
Input: >AZOBR_RS13260 FitnessBrowser__azobra:AZOBR_RS13260 VAQTRKSDKLTLLPLVALVVGSMIGGGVFNLPSDMSKGASPGAILIGWMITGIGMMMLAF VYQNLAVRKPNLNAGPYAYAKAGFGPFVGFNSAWGYWLSAFLGNVAYAVAIFSALSHFFP IFGDGNNLPSIVGASLCLWLIHALVLSGIKQAAFVNVVTSIAKLVPLFLFVLVAIVGFHW DRFTVDFWGTGAGSGTGGLGSVMEQVKSTMLVTLWVFIGIEGASVYSARAARRSDVGRAT VIGFVGALGIYVLVSLLATGVLRQPELADLKVPSMAGVFESLVGPWGAALINIGLVISVG GAFLSWTLLCAEIPYTCGRDGTFPKWFAAENANGSPVNALWATNLLIQLFLALSFFSRSA YQFFYFIASVAILPPYVLSGAYALKLALTGEGYGAESRTKGILVGALATAYGLWLVYAAG LQYLLMCAVLFAPGILVYVRARREHGERTFTGVEMAIAAAIAVLAVLAAWLMWTGRISPL
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server